Company intelligence / Profile preview

MouSensor

New York, New York, United States

Ownership: Private
Employees: ~4
Development stage: Other

Overview

MouSensor (now Yesse Technologies) is developing a genetic and chip-based platform that expresses mammalian odorant receptors in engineered mice (MouSensors) and ex vivo formats, aiming to digitize the sense of smell for applications in fragrance, flavor, and medical diagnostics; work is at pre-clinical, proof-of-concept stage with no therapeutic or diagnostic product yet in human trials.[1][2][3][4][5]

Therapeutic areas: OncologyNeurology
Modalities: DeviceBiologic
Industry: Metabolite Diagnostics

Partnerships

imecimec.xpandVLAIOMichael J. Fox Foundation

Beyond the preview

Go deeper on MouSensor.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on MouSensor.

Explore the full profile